Filter
3459
Filtered Results: 3459
Text search:
national
drug
authority
Featured
Recommendations
319
New Publications
977
Language
Document type
No document type
2013
Studies & Reports
547
Guidelines
465
Manuals
179
Strategic & Response Plan
145
Training Material
39
Fact sheets
37
Situation Updates
19
Resource Platforms
5
Infographics
4
Brochures
3
Online Courses
3
Countries / Regions
India
176
Global
124
Kenya
103
Uganda
96
Ethiopia
95
Western and Central Europe
89
Nigeria
68
South Africa
68
Liberia
65
Ghana
64
Tanzania
61
Latin America and the Carribbean
56
Sierra Leone
55
Zambia
53
Myanmar / Burma
51
Nepal
50
Bangladesh
50
Malawi
49
Rwanda
42
Africa
40
Eastern Europe
36
Ukraine
35
Namibia
32
Zimbabwe
31
Cambodia
30
South–East Asia Region
30
Asia
29
Philippines
26
Lesotho
22
Congo, Democratic Republic of
19
Botswana
18
Syria
15
Indonesia
14
Mozambique
13
Eastern Europe and Central Asia
13
Senegal
12
South Sudan
12
Eswatini/ Swaziland
12
Venezuela
11
Burkina Faso
10
Haiti
10
Russia
10
Germany
9
East and Southern Africa
9
Vietnam
9
Brazil
9
Colombia
8
Albania
8
Guinea
8
West and Central Africa
8
Middle East and North Africa
8
Pakistan
8
Laos
7
USA
7
Tajikistan
6
Thailand
6
China
6
Cameroon
6
Afghanistan
6
Western Pacific Region
6
Sri Lanka
6
Georgia
6
North America
5
Moldova
5
Sudan
5
Central African Republic
5
North Macedonia
4
Mexico
4
Iran
4
Jordan
4
Yemen
4
Iraq
4
Timor Leste/ East Timor
3
El Salvador
3
Turkey
3
Benin
3
Fiji
3
Jamaica
3
Lebanon
3
Papua New Guinea
3
Palestine
3
Mali
3
Libya
3
Somalia
3
Serbia
2
Chile
2
Kyrgyzstan
2
Uzbekistan
2
Peru
2
Morocco
2
Mongolia
2
Armenia
2
Hungary
2
Saudi Arabia
2
United Kingdom
2
Portugal
2
Bolivia
2
Argentina
2
Poland
2
Honduras
2
Bhutan
2
North Korea
1
Switzerland
1
Australia
1
Kazakhstan
1
Canada
1
Estonia
1
Qatar
1
Bulgaria
1
Italy
1
Dominican Republic
1
Guinea-Bissau
1
Lithuania
1
Ireland
1
Paraguay
1
Gabon
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Spain
1
Belarus
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Belize
1
Costa Rica
1
Panama
1
Nicaragua
1
Egypt
1
Romania
1
Greece
1
Angola
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1302
Clinical Guidelines
316
Public Health
189
Women & Child Health
144
Key Resources
131
Pharmacy & Technologies
58
Capacity Building
50
Toolboxes
HIV
366
TB
319
Mental Health
283
AMR
207
COVID-19
149
Pharmacy
140
NTDs
120
Rapid Response
81
Malaria
70
Caregiver
66
Ebola & Marburg
58
Planetary Health
51
NCDs
50
Refugee
49
Conflict
45
Global Health Education
39
Disability
33
Health Financing Toolbox
21
Polio
18
Zika
17
Natural Hazards
15
Specific Hazards
14
Cholera
14
Social Ethics
5
This working paper was conceived to offer practical tips and suggestions on how to establish and sustain the multisectoral coordination needed to develop and implement National Action Plans on AMR (NAPs). It is intended for anyone with responsibility for addressing AMR at country level. Drawing on b...
This document provides guidance to Member States in the WHO European Region that wish to conduct behavioural insights studies related to COVID-19. Studies can be used to monitor public knowledge, risk perceptions, behaviours and trust with the overall aim to inform national COVID-19 outbreak respons...
WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regional and Country Offices has been invaluable: in ga...
Available in Arabic, Chinese, English, French, Russian and Spanish. You can download a summary of the main report and background documents!
The report demonstrates that the current system—at both national and international levels— was not adequate to protect people from COVID-19. The time it t...
This working paper was conceived to offer practical tips and suggestions on how to establish and sustain the multisectoral coordination needed to develop and implement National Action Plans on AMR (NAPs). It is intended for anyone with responsibility for addressing AMR at country level. Drawing on b...
In September, 2018, the first international Medicine Quality and Public Health Conference was held at Oxford University, UK, to discuss opportunities and solutions to ensure that all people have access to affordable and quality-assured medical products. Delegates developed the short Oxford Statement...
The purpose of this document is to present and promote the minimum requirements for IPC programmes at the national and health care facility level, identified by expert consensus according to available evidence and in the context of the WHO core components.
The minimum requirements are defined as: I...
2nd edition - Published in 2003, the first WHO/HAI medicine prices manual Medicine Prices – A
New Approach to Measurement Draft for field-testing provides a draft methodology and tools to conduct national medicine prices and availability surveys. This second edition of the survey manual has been...
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level.
The aim of the document is to assist Member States and releva...
Practical actions in cities to strengthen preparedness for the COVID-19 pandemic and beyond
recommended
This document accompanies the interim guidance on “Strengthening Preparedness for COVID-19 in cities and urban settings”. It provides local authorities, leaders and policy-makers in cities with a checklist tool to ensure that key areas have been covered. An excel version that local authorities m...
July 2018
This fourth edition of the Unitaid/WHO market and technology landscape: HIV rapid diagnostic tests for self-testing report summarizes the current HIV testing gap; the challenges facing efforts to scale up; and the potential role HIV self-testing (HIVST) could play to achieve the United...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
The curriculum, which complements the national pediatric ART training, was finalized in 2011 and was subsequently implemented nationally. The training curriculum includes a 15-module Trainer Manual, a Participant Manual, and accompanying PowerPoint slides.
Module 5
Monitoring and Evaluation
October 2018
Module 5: Monitoring and evaluation. This module is for people responsible for monitoring PrEP programmes at the national and site levels. It provides information on how to monitor PrEP for safety and effectiveness, suggesting core and additiona...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s...
The aim of the people-centred framework is to help countries to develop fully prioritized and budgeted NSPs based on a culture of making full use of the available data, which are aligned with national planning cycles and which provide the basis for a robust national response that can accelerate prog...
The update of the ESTC was conducted as a joint endeavour with ERS, consulting experts from international societies and organisations, national TB programmes, civil society and affected communities. The second edition of the ESTC includes 21 standards in the areas of diagnosis, treatment, HIV and co...
This regional advocacy strategy on HIV and AIDS, tuberculosis (TB) and sexually transmitted infetions (STIs) is intended for use by Southern African Development Community (SADC) Member States at a national level. This is an overall advocacy strategy highlighting the most important issues relating to...
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
recommended
The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of n...
WHO Recommendations 2018 Update
The primary audience for these recommendations includes health professionals who are responsible for developing national and local health care guidelines and protocols (particularly those related to PPH prevention and treatment) and those involved in the provision of...
